Early HBV Treatment
How to Implement Earlier Hepatitis B Treatment

Released: March 26, 2024

Activity

Progress
1
Course Completed

In this episode, Mark S. Sulkowski, MD, FIDSA, FAASLD; Tatyana Kushner, MD, MSCE; Paul Y. Kwo, MD; and patient advocate Jacki Chen, PhD, consider barriers and solutions for more expansive HBV treatment in the United States. Topics include:

  • Patient subgroups to consider for treatment outside guideline criteria
  • Adverse event and cost-effectiveness considerations
  • Integration of patient perspectives in wider treatment